Disclosure Of Entity's Operating Segments [Text Block]

Tchaikapharma High Quality Medicines AD - Filing #6023734

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
42 431 BGN
40 105 BGN
Depreciation and amortisation expense
3 877 BGN
4 231 BGN
Tax expense (income)
168,000 BGN
20,000 BGN
Profit (loss) before tax
1 564 BGN
624,000 BGN
Profit (loss)
- BGN
- BGN
- BGN
- BGN
1 396 BGN
1 396 BGN
1 396 BGN
604,000 BGN
604,000 BGN
- BGN
- BGN
604,000 BGN
- BGN
- BGN
Assets
117 457 BGN
117 311 BGN
Liabilities
18 638 BGN
20 175 BGN
Cash flows from (used in) operating activities
2 023 BGN
3 486 BGN
Cash flows from (used in) investing activities
1 573 BGN
2 907 BGN
Cash flows from (used in) financing activities
457,000 BGN
555,000 BGN
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.